Improving immune responses to vaccines in older adults
Programming Durable Immune Responses To Vaccination
This study is looking at how mRNA vaccines might boost the immune system in people aged 65 and older, comparing them to regular flu shots to see if they can provide a stronger and longer-lasting protection.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11020937 on NIH RePORTER |
What this research studies
This research investigates how mRNA-based vaccines can enhance immune responses, particularly in older adults aged 65 and above. It focuses on understanding the mechanisms behind the immune response generated by these vaccines, comparing them to traditional influenza vaccines. The study aims to determine if mRNA vaccines can induce a stronger and longer-lasting immune reaction, which is crucial for effective vaccination in the elderly population. By exploring these aspects, the research seeks to improve vaccine efficacy and durability in older individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 65 and older who are interested in receiving vaccinations.
Not a fit: Patients under the age of 65 or those with specific contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide longer-lasting protection against influenza and other viral infections for older adults.
How similar studies have performed: Previous research has shown promising results with mRNA vaccines, particularly in the context of COVID-19, suggesting potential for success in similar applications.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ellebedy, Ali Hassan — Washington University
- Study coordinator: Ellebedy, Ali Hassan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.